Safety and efficacy of mixing cetrorelix with follitropin alfa: a randomized study

Fertility and Sterility

Volumn 94, Issue 1, 2010, Pages 179-183

  Lin, Yu Hung ^a,b,c   Wen, Yeong Ray ^a,d   Chang, Yuanmay ^a,d   Seow, Kok Min ^a,b,e   Hsieh, Bih Chwen ^a,b   Hwang, Jiann Loung ^a,d   Tzeng, Chii Ruey ^d  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e LI SHIN HOSPITAL   (Taiwan)

Author keywords

Cetrorelix; FSH; premature LH surge; visual analogue scale

Indexed keywords

CETRORELIX; ESTRADIOL; LUTEINIZING HORMONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CELL COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; HORMONE RELEASE; HUMAN; HUMAN CELL; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; NIDATION; OOCYTE; PREGNANCY RATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SKIN BRUISING; SKIN REDNESS; SWELLING;

ADULT; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY, FEMALE; OVARIAN HYPERSTIMULATION SYNDROME; PREGNANCY; PROSPECTIVE STUDIES; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 77952545779     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.02.062     Document Type: Article

References (12)

1. Marrs R., Meldrum D., Muasher S., Schoolcraft W., Werlin L., and Kelly E. Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reprod BioMed Online 8 (2003) 175-182
2. Marshall D.C., Raike E., De Silva M., and Nardi R.V. Mixed-protocol, same-syringe combination of gonadotropins: compatiblility of new, highly purified, human-derived FSH (Bravelle) and hMG (Repronex). Today's Ther Trend 19 (2001) 213-224
3. Keye W.R., Marrs R.P., Check J.H., Schnell V., Surrey M., and Marshall D.C. Evaluation of mixed protocols with Bravelle® (human-derived FSH) and Repronex® (hMG) to assess clinical efficacy (EMBRACE) in wome undergoing in vitro fertilization. Fertil Steril 82 (2004) 348-357
4. Rice V.M., Silverberg K., Karst A., Ormand R., Vaughn T., and Hansard L. Patient tolerance to recombinant human follicle stimulating hormone (r-hFSH, Gonal-F) and leuprolide acetate (LA, Lupron) administered in single or separate injections in women undergoing IVF; preliminary results. Fertil Steril 74 (2000) S231
5. Silverberg K., Rice V., Ormand R., Karst A., Vaughn T., and Hansard L. Recombinant human FSH (Gonal-F) and leuprolide acetate (LA, Lupron) adminstered in single or separate injection in women undergoing IVF: preliminary results. ESHRE Annu Meet (2000) O-107
6. Lesser C., Alper M.M., and Ezcurra D. Outcome of 934 IVF cycles using a single daily mixed injection combining GnRH agonists, rFSH alone or with rhLH or hMG add-back for COH. Fertil Steril 90 (2008) S479
7. Klipstein S., Reindollar R.H., Regan M.M., and Alper M.M. Initiation of the gonadotropin-releasing hormone antagonist ganirelix for in vitro fertilization cycles in which the lead follicle is >14 mm. Fertil Steril 81 (2004) 714-715
8. Al-Inany H., and Aboulghar M. GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod 17 (2002) 874-885
9. Olivennes F., Belaisch-Allart J., Emperaire J., Dechaud H., Alvarex S., Nicollet B., et al. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix or a depot formula of an LH-RH agonist (triptorelin). Fertil Steril 73 (2000) 314-320
10. The European and Middle East Orgalutran Study Group. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod 16 (2001) 644-651
11. Albano C., Felberbaum R.E., Smitz J., Riethmüller-Winzen H., Engel J., Diedrich K., et al. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. Hum Reprod 15 (2000) 526-531
12. Højgaard A., Ingerslev H.J., Dinesen J., and Friendly I.V.F. patient opinions. Hum Reprod 16 (2001) 1391-1396